Related Experiment Videos
Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein
Mateja Mancek1, Primoz Pristovsek, Roman Jerala
1National Institute of Chemistry, Hajdrihova 19, Ljubljana, SI-1000, Slovenia.
Abstract:
Members of the toll-like receptor family are crucial in recognition of microbial pathogens as part of innate immune response. MD-2, an accessory protein to TLR4, present on the extracellular side of the membrane is needed to initiate the signal transduction. We have identified a 15 amino acid region of human MD-2 that contains several features of other lipopolysaccharide (LPS) binding proteins and peptides. In vitro LPS neutralization by this peptide was observed and confirmed by 2D transferred NOESY NMR experiments. NMR experiments have also shown binding of the MD-2 peptide to lipoteichoic acid (LTA) but not to peptidoglycan. Furthermore this peptide inhibited growth of gram-negative and to a lower extent of some gram-positive bacteria. Our results indicate that this region of MD-2 might be responsible for binding of LPS and confirms the role of MD-2 as an accessory protein in LPS signaling bestowing the Toll receptors their specificity.
Insights
Researchers identified a key region in the MD-2 protein that binds to lipopolysaccharide (LPS) and lipoteichoic acid (LTA), inhibiting bacterial growth and confirming MD-2's role in innate immunity signaling.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Background:
- Toll-like receptors (TLRs) are vital for innate immunity, recognizing microbial pathogens.
- MD-2 is an essential accessory protein for TLR4-mediated signaling.
- Lipopolysaccharide (LPS) is a major component of Gram-negative bacterial outer membranes, triggering immune responses.
Purpose of the Study:
- To identify and characterize the LPS-binding region of the human MD-2 protein.
- To investigate the functional role of this MD-2 region in microbial recognition and immune signaling.
- To explore the potential of this region as a therapeutic target.
Main Methods:
- Peptide identification from human MD-2 sequence.
- In vitro LPS neutralization assays.
- 2D transferred NOESY Nuclear Magnetic Resonance (NMR) experiments for binding studies.
- Bacterial growth inhibition assays (Gram-negative and Gram-positive).
Main Results:
- A 15-amino acid region of MD-2 was identified with features of LPS-binding proteins.
- This peptide demonstrated in vitro LPS neutralization.
- NMR confirmed binding of the MD-2 peptide to LPS and lipoteichoic acid (LTA), but not peptidoglycan.
- The peptide inhibited the growth of Gram-negative bacteria and, to a lesser extent, some Gram-positive bacteria.
Conclusions:
- The identified 15-amino acid region of MD-2 is likely responsible for LPS binding.
- This finding confirms MD-2's crucial role as an accessory protein in LPS signaling.
- The results highlight the specificity conferred by MD-2 to Toll receptors in pathogen recognition.